BioCentury
ARTICLE | Clinical News

Immuno-C: Filed IND; expects to start Phase I trial in 25 healthy volunteers, testing dose and measuring how much crosses from gut into the bloodstream

June 20, 1994 7:00 AM UTC

Biomune Systems Inc. (BIMED), Salt Lake City Product: Immuno-C, consisting of IgG antibodies isolated from ultrafiltrate of cow colostrum Indication: Cryptosporidiosis infection in immune-deficient pa...